Pacific Biosciences Of California (PACB) Shares Outstanding (Diluted) (2014 - 2026)
Pacific Biosciences Of California (PACB) Shares Outstanding (Diluted) (2014 - 2026) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Dil.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.43 Bn | 193.83 Bn | 7.27 Bn | 1.74 Bn |
| 2 | Stryker | 126.52 Bn | 123.04 Bn | 4.50 Bn | 386.00 Mn |
| 3 | Medtronic | 118.76 Bn | 109.54 Bn | 6.41 Bn | 1.29 Bn |
| 4 | Boston Scientific | 73.25 Bn | 72.71 Bn | 3.85 Bn | 1.47 Bn |
| 5 | Edwards Lifesciences | 52.20 Bn | 47.95 Bn | 1.35 Bn | 577.60 Mn |
| 6 | Dexcom | 34.51 Bn | 32.56 Bn | 830.00 Mn | 390.10 Mn |
| 7 | GE HealthCare Technologies | 33.75 Bn | 31.65 Bn | 2.18 Bn | 454.00 Mn |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | 968.57 Mn |
| 9 | Steris | 23.09 Bn | 22.61 Bn | 684.20 Mn | 97.90 Mn |
| 10 | Pacific Biosciences Of California | 388.60 Mn | 151.73 Mn | 12.64 Mn | 310.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 310.66 Mn |
| Mar 31, 2026 | 305.82 Mn |
| Dec 31, 2025 | 299.96 Mn |
| Sep 30, 2025 | 300.84 Mn |
| Jun 30, 2025 | 300.16 Mn |
| Mar 31, 2025 | 296.86 Mn |
| Dec 31, 2024 | 288.37 Mn |
| Sep 30, 2024 | 272.92 Mn |
| Jun 30, 2024 | 272.39 Mn |
| Mar 31, 2024 | 269.58 Mn |
| Dec 31, 2023 | 253.63 Mn |
| Sep 30, 2023 | 255.00 Mn |
| Jun 30, 2023 | 250.07 Mn |
| Mar 31, 2023 | 242.03 Mn |
| Dec 31, 2022 | 224.55 Mn |
| Sep 30, 2022 | 225.12 Mn |
| Jun 30, 2022 | 224.50 Mn |
| Mar 31, 2022 | 222.29 Mn |
| Dec 31, 2021 | 204.14 Mn |
| Sep 20, 2021 | 198.57 Mn |